Related Experiment Videos

Acute toxicity of maytansine in F344 rats

Cancer Treatment Reports
|October 1, 1977
PubMed

Insights

Maytansine is toxic to rats, with a 14-day LD50 of 0.48 mg/kg. This potent anti-mitotic agent causes cell damage in rapidly dividing tissues, leading to organ damage and neurological signs.

Area of Science:

  • Pharmacology
  • Toxicology
  • Cell Biology

Background:

  • Maytansine is a potent antimitotic agent.
  • Understanding its toxicity is crucial for potential therapeutic applications and safety assessments.

Purpose of the Study:

  • To determine the toxicity profile of maytansine following subcutaneous administration in rats.
  • To investigate the dose-response relationship and identify target organs.

Main Methods:

  • Subcutaneous administration of maytansine to 5-week-old male F344 rats.
  • Determination of the 14-day lethal dose 50 (LD50).
  • Histopathological examination of tissues and clinical observation.

Main Results:

  • The 14-day LD50 was determined to be 0.48 mg/kg.
  • Dose-dependent effects included body weight loss and diarrhea.
  • Maytansine induced mitotic arrest and subsequent necrotizing and atrophic lesions in the gastrointestinal tract, thymus, spleen, bone marrow, and testes.
  • Hemorrhagic lesions, neurotoxicity (ataxia, chromatolysis, vacuolation), and local skin reactions were observed.

Conclusions:

  • Maytansine exhibits significant toxicity in rats, primarily targeting rapidly dividing cells.
  • The observed pathological changes highlight the potential for severe systemic toxicity and localized effects at the administration site.

Related Concept Videos